February 4, 2025 03:41 PM EST
R&D
FDA+

Af­ter re­launch, Roche gets FDA ap­proval for oc­u­lar im­plant in di­a­bet­ic mac­u­lar ede­ma

Lei Lei Wu

News Reporter

Roche sub­sidiary Genen­tech an­nounced Tues­day that it won FDA ap­proval for its eye im­plant Susvi­mo to treat di­a­bet­ic mac­u­lar ede­ma, a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Pfiz­er says it has at least $10B avail­able for deals in 2025, with a fo­cus on pipeline

We’re about to find out which RFK Jr. will show up at HHS

New study will try to stop Alzheimer’s decades be­fore it be­gins, us­ing ex­per­i­men­tal Eli Lil­ly drug

Up­dat­ed: RFK Jr. ad­vances out of Sen­ate com­mit­tee with Cas­sidy’s sup­port

Astel­las shakes up man­age­ment de­spite im­pres­sive nine-month earn­ings

Il­lu­mi­na added to Chi­na's black­list fol­low­ing Biose­cure Act, tar­iffs

A service from the Financial Times